http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-021786-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
filingDate 1999-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-021786-A1
titleOfInvention DERIVATIVES OF AZABICICLOHEPTANO N-REPLACED ITS OBTAINING AND USE
abstract N-substituted 3-azabicyclo- [3.2.0] heptane derivatives of formula (1) wherein R1 means fluorine or chlorine, R2 and R3 mean hydrogen or alkyl with 1-3 carbon atoms and R4 means chlorine, methyl, nitro or amino, and its salts with physiologically tolerated acids. The free 3-azabicyclo [3.2.0] heptane derivatives of the formula (1) can be customarily transformed into the acid addition salts of a physiologically tolerated acid, preferably by mixing a solution with an equivalent equivalent of the corresponding acid. Pharmaceutically tolerated acids are, for example, hydrochloric acid, phosphoric acid, sulfuric acid, methanesulfonic acid, amidosulfonic acid, maleic acid, fumaric acid, oxalic acid, tartaric acid or citric acid. These compounds have valuable pharmacological properties. They can be used as neuroleptics (especially atypical), antidepressants, sedatives, hypnotics, central nervous system protectors or products for the treatment of cocaine dependence. Numerous of these qualities of effected can be presented in combination in the compound of the invention.
priorityDate 1999-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421928483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409381142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21962587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311

Total number of triples: 39.